Nature of the Business - Additional Information (Details) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended						9 Months Ended
	Dec. 14, 2022 USD ($) shares	Nov. 17, 2022 USD ($) $ / shares shares	Nov. 30, 2022	Sep. 30, 2022 USD ($) shares	Jun. 30, 2022 USD ($) shares	Mar. 31, 2022 USD ($) shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2021 USD ($) shares	Mar. 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($) shares	Nov. 18, 2022 shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 shares
Organization Consolidation Presentation Of Financial Statements [Line Items]
Description of reverse stock spilt										In November 2022, the Company effected a 1-for-2.466 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios of each series of the Company’s preferred stock (see Note 9).
Net loss				$ 9,198	$ 5,820	$ 7,220	$ 2,440	$ 2,548	$ 6,912	$ 22,238	$ 11,900
Accumulated deficit				47,103						47,103			$ 24,865
Cash, cash equivalents and investments				$ 76,800						76,800
Net proceeds from IPO and Concurrent Private Placement										92,400
Net proceeds from sale of stock including partial exercise of underwriters option to purchase additional shares										$ 104,500
Convertible preferred stock outstanding | shares				27,471,911						27,471,911			27,471,911
Convertible Preferred Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Convertible preferred stock outstanding | shares				27,471,911	27,471,911	27,471,911	9,904,806	9,904,806	9,904,806	27,471,911	9,904,806		27,471,911	4,422,350
Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares									336,575
Initial Public Offering
Organization Consolidation Presentation Of Financial Statements [Line Items]
Description of reverse stock spilt										In connection with the IPO, the Company effected a 1-for-2.466 reverse stock split of the Company’s common stock and adjusted the ratio at which the Company’s preferred stock is convertible into common stock, the number of shares available for issuance under the 2019 Stock Incentive Plan (“2019 Plan”) and the number of options and exercise prices of options granted under the 2019 Plan as a result of the 1-for-2.466 reverse stock split.
Underwriters | Scenario Forecast
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares	1,035,540
Anticipated Proceeds from Stock Options Exercised	$ 12,900
IPO and Option Exercise | Scenario Forecast
Organization Consolidation Presentation Of Financial Statements [Line Items]
Aggregate net proceeds received from IPO and option exercise	99,800
Payment of underwriting discounts and commissions	7,500
Estimated offering expenses payable	$ 2,900
Subsequent Event
Organization Consolidation Presentation Of Financial Statements [Line Items]
Reverse stock split conversion ratio		0.406	0.406
Aggregate net proceeds from concurrent private placement		$ 4,700
Subsequent Event | Convertible Preferred Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Convertible preferred stock outstanding | shares												0
Subsequent Event | Initial Public Offering
Organization Consolidation Presentation Of Financial Statements [Line Items]
Initial public offering price per share | $ / shares		$ 12.50
Subsequent Event | Initial Public Offering | Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares		7,550,000
Subsequent Event | Initial Public Offering | Common Stock | Convertible Preferred Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Convertible preferred stock converted into common stock shares | shares		11,140,262
Subsequent Event | Concurrent Private Placement
Organization Consolidation Presentation Of Financial Statements [Line Items]
Initial public offering price per share | $ / shares		$ 12.50
Subsequent Event | Concurrent Private Placement | Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares		400,000
Subsequent Event | Underwriters | Common Stock
Organization Consolidation Presentation Of Financial Statements [Line Items]
Issuance of common stock | shares		1,132,500